CA
AMGN icon

Capitolis Advisors’s Amgen AMGN Stock Holding History

Capitolis Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,800
Closed -$435K – 127
2022
Q1 		$435K Sell
1,800
-526,633
-100% -$121M 0.02% 107
2021
Q4 		$119M Buy
528,433
+30,632
+6% +$6.47M 0.71% 30
2021
Q3 		$101M Buy
497,801
+419,152
+533% +$96.5M 0.92% 28
2021
Q2 		$19.2M Buy
78,649
+42,493
+118% +$10.5M 0.23% 106
2021
Q1 		$9M Sell
36,156
-24,913
-41% -$5.94M 0.16% 135
2020
Q4 		$14M Buy
+61,069
New +$14.1M 0.23% 106

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capitolis Advisors's AMGN Position: Q2 2022 in Review

Capitolis Advisors sold out of Amgen (AMGN) in Q2 2022, closing a stake of 1,800 shares — an estimated $435K sold.

Capitolis Advisors first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $119M in Q4 2021. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Capitolis Advisors reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Capitolis Advisors sold 1,800 Amgen shares in Q2 2022, an estimated $435K.
  • Capitolis Advisors first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • Capitolis Advisors's Amgen position peaked at $119M in Q4 2021.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Capitolis Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.